Erythromycinestolate

Basic Information

View in Editor

CAS Number

3521-62-8

Molecular Formula

C52H97NO18S

Molecular Weight

1056.39 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Ketones

Basic Chemical Raw Materials Organic Chemicals Esters

Basic Chemical Raw Materials Organic Chemicals Ethers

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Fine Chemicals Surfactants Anionic Surfactants

Polymers and Plastics Thermoplastics Polyolefins

Laboratory Chemicals Research Chemicals Biochemical Reagents

Basic Physical Properties

Melting Point

135-140°C

Boiling Point

827.7°C at 760 mmHg

Water Solubility

Freely soluble in organic solvents, practically insoluble in water /n

Flash Point

>110°(230°F)

Solubility

chloroform: soluble4.0ML, clear, colorless (200 mg + 4.0 mL Chloroform)

Refractive Index

1.6550 (estimate)

SMILES

View in Editor

CCC(=O)O[C@H]1[C@@H](O[C@@H](C[C@@H]1N(C)C)C)O[C@@H]1[C@@H](C)[C@H](O[C@@H]2O[C@@H](C)[C@@H]([C@](C2)(C)OC)O)[C@@H](C)C(=O)O[C@H](CC)[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]1(C)O)C)C)O)(C)O.CCCCCCCCCCCCOS(=O)(=O)O

InChI

InChI=1S/C40H71NO14.C12H26O4S/c1-15-27-40(11,48)33(44)22(5)30(43)20(3)18-38(9,47)35(55-37-32(53-28(42)16-2)26(41(12)13)17-21(4)50-37)23(6)31(24(7)36(46)52-27)54-29-19-39(10,49-14)34(45)25(8)51-29;1-2-3-4-5-6-7-8-9-10-11-12-16-17(13,14)15/h20-27,29,31-35,37,44-45,47-48H,15-19H2,1-14H3;2-12H2,1H3,(H,13,14,15)/t20-,21-,22+,23+,24-,25+,26+,27-,29+,31+,32-,33-,34+,35-,37+,38-,39-,40-;/m1./s1

InChIKey

AWMFUEJKWXESNL-JZBHMOKNSA-N

LogP

6.47320000000001

pKa

6.9(at 25℃)

Topological Polar Surface Area

263.58 Å²

Hydrogen Bond Donor/Acceptor

5 / 19

Complexity

1550

Safety Information

View Safety Information

Hazard Statement

H302 Harmful if swallowed
Acute toxicity, oral

H315 Causes skin irritation
Skin corrosion/irritation

H319 Causes serious eye irritation
Serious eye damage/eye irritation

H335 May cause respiratory irritation
Specific target organ toxicity, single exposure; Respiratory tract irritation

Sensitiveness

Light Sensitive

Toxicity

LD50 orally in rats: >5000 mg/kg (Goldenthal)

Synonyms & References

English

erythromycin estolate
eritroger
eromycin
erythromycin,propionate(ester),compd.withmonododecylsulfate(1:1)
erythromycin5-(3-propionate)dodecylsulfate
erythromycinpropionate,compd.withdodecylsulfate
erythromycinpropionatelaurylsulfate
erythromycinpropionyllaurylsulfate
ERYTHROMYCIN ESTOLATE, USP35
Erythromycin 2'-propionate dodecyl sulfate
Erythromycin 2-Propionate Dodecyl Sulfate
Ilosone
erythromycin propionate lauryl sulfate
Lauromicina
Stellamicina
Marcoeritrex
Biomicron
Roxomicina
Estomicina
Eriscel
Erythromycin estorate
Neo-erycinum
Lubomycine B
PELS
XRJ2P631HP
Prospiocine
Erytrarco
Ery-Toxinal dodecylsulfate
Erythromycinestolate
Erythromycine estolate
Propionylerythromycin lauryl sulfate

MDL Number

MFCD00084691

Customs Code

29419000

FAQ

What is Erythromycinestolate (CAS: 3521-62-8)?

Erythromycinestolate (CAS: 3521-62-8) is a derivative of erythromycin, a macrolide antibiotic. It functions as an ester form used in pharmaceutical formulations, typically for veterinary applications. The compound has a molecular formula of C37H67NO13 and is characterized by its white to off-white powder appearance, solubility in ethanol, and stability under controlled conditions.

What are the main uses of Erythromycinestolate (CAS: 3521-62-8)?

Erythromycinestolate (CAS: 3521-62-8) is primarily used in veterinary medicine as an antibiotic for treating bacterial infections in animals. It is also employed in pharmaceutical research for its antimicrobial properties and as a prodrug in drug development. Its applications may include livestock health management and antimicrobial therapy in specialized medical settings.

Is Erythromycinestolate (CAS: 3521-62-8) safe?

Erythromycinestolate (CAS: 3521-62-8) is generally considered safe when used as directed in veterinary or pharmaceutical contexts. However, it should be handled with care to avoid inhalation or skin contact. Safety guidelines recommend following OSHA and EPA standards, and it is classified as low toxicity in controlled exposure scenarios.

How should Erythromycinestolate (CAS: 3521-62-8) be stored?

Erythromycinestolate (CAS: 3521-62-8) should be stored in a cool, dry place away from light to maintain stability. It is best kept in airtight containers, preferably dark glass bottles, to prevent degradation. Storage conditions should be controlled at 2-8°C, with humidity levels below 60%, and it should be protected from moisture and direct sunlight.